This report discusses the House Judiciary Committee's announcement that they would hold a full committee markup hearing on Wednesday, January 17 for H.R. 4170, the Disclosing Foreign Influence Act (DFIA).

This report discusses the Supreme Court's decision to decline to review the case of "Perry Capital LLC. v. Murchin" which denied the claims of Fannie Mae and Freddie Mac shareholders against the federal government. It also discusses some of the plaintiffs desire to seek legislative reform from Congress to change the law governing profit transfers from Fannie Mae and Freddie Mac.

This report provides a brief overview of the higher education tax benefits that are currently available to students and their families. These tax benefits can be divided into three groups: incentives for current year expenses, incentives for preferential tax treatment of student loan expenses, and incentives for saving for college.

This report provides a brief history of FDA drug regulation, describes FDA's early risk management programs, and focuses on the agency's current risk management authorities, specifically risk evaluation and mitigation strategies (REMS). The report also discusses issues that have arisen as a result of REMS, particularly the impact on generic drug competition. While this report generally focuses on REMS in the context of generic drug development, the issues discussed are also relevant to biological and biosimilar product development.

This report discusses the Prescription Drug User Fee Act (PDUFA) and its reauthorization by Congress as PDUFA I.

This report examines the Minority Small Business and Capital Ownership Development Program's (8(a) Program) historical development, key requirements, administrative structures and operations, and the SBA's oversight of 8(a) firms. It also discusses two SBA programs designed to support 8(a) firms, the 7(j) Management and Technical Assistance Program and the 8(a) Mentor-Protégé Program, and provides various program statistics. It concludes with an analysis of current Program 8(a) issues.

This report examines the Small Business Administration's (SBA's) appropriations (new budget authority, minus rescissions and sequestration) over time, focusing on developments and trends since FY2000.

This report describes the Small Business Administration's programs and funding sources.

This report provides an overview of the TRIO programs which provide support services to disadvantaged student to promote achievement in post-secondary education.

This report discusses the Federal Aviation Administration (FAA) programs including organizational structures, updates on activities and reforms, funding sources, and other relevant information.

This report summarizes the issue of development of major combat systems for the Army and the proposed solution: Army Futures Command. The report ends with possible issues for Congress to consider.

This report provides background on "Marbury v. Madison" and the upcoming case of Dalmazzi v. United States" which challenges the jurisdiction of the Supreme Court over the Court of Appeals for the Armed Forces (CAAF) and concludes by exploring the potential ramifications of the jurisdictional question "Dalmazzi" poses.

This report gives a brief overview of taxes and tax law regarding capital gains.

This report discusses the possibility of a new military service branch -- the Space Force -- with the goal of asserting "American dominance in space."

This report discusses nuclear energy and various issues and concerns related to it use in six topics: radioactive waste, economic viability, safety, technological advances, security and emergency plans, and nuclear weapon nonproliferation.

This report evaluates the National Flood Insurance Program's (NFIP) borrowing authority to receive loans from the U.S. Department of the Treasury, particularly in the context of major floods, and discusses the current financial situation of the NFIP.

This report provides a short overview of what would happen if the National Flood Insurance Program (NFIP) were not to be reauthorized by July 31, 2018, and allowed to lapse.

This report discusses the Fifth Amendment's Double Jeopardy Clause; although the Clause provides that no person shall "be subject for the same offense to be twice put in jeopardy of life or limb," the Supreme Court has made clear that that protection has its limits.

This report discusses the ongoing conflict in Syria and past and current U.S. policies regarding the conflict and U.S. involvement in it. Topics covered include U.S. military aid and humanitarian assistance to groups in Syria, proposed legislation related to Syria n Congress, current U.S. policy aims, and recent events in Syria both diplomatically and militarily.

This report discusses the Committee on Foreign Investment in the United States (CFIUS) which is an interagency body comprised of nine Cabinet members, two ex officio members, and other members as appointed by the President, that assists the President in overseeing the national security aspects of foreign direct investment in the U.S. economy. Various legislative and executive actions that would effect the operations of CFIUS are also discussed.

This report discuses policy options for Congress to consider in regard to law enforcement reform. Over the past few years, several high-profile police-involved shootings and alleged instances of excessive force have generated congressional interest in state and local policing.

This report discusses the case of "Lucia v. Securities and Exchange Commission (SEC)" which is scheduled to be heard by the Supreme Court. The case addresses whether administrative law judges(ALJs) within the SEC are "Officers of the United States" (officers) who must be appointed in accordance with the Appointments Clause of Article II of the Constitution.

This report provides a description of current programs and provisions in Title II-A and identifies a number of the key issues that may be part of the debate over the reauthorization of the Higher Education Act (HEA).

This report is an update of a previous report discussing the case of "Allergan Inc. v. Teva Pharmaceuticals USA Inc." which deals with patent law and the rights of brand-name pharmaceutical companies and generic pharmaceutical companies as well as Native American tribes sovereign rights because the St. Regis Mohawk Tribe is a co-plaintiff in the case. The case is currently in the appeals process.